379 related articles for article (PubMed ID: 18929130)
1. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
Seki M; Lipton SA
Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
[TBL] [Abstract][Full Text] [Related]
2. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
3. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
4. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine.
Hare WA; Wheeler L
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2940-8. PubMed ID: 19136701
[TBL] [Abstract][Full Text] [Related]
5. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro.
Luo X; Heidinger V; Picaud S; Lambrou G; Dreyfus H; Sahel J; Hicks D
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1096-106. PubMed ID: 11274091
[TBL] [Abstract][Full Text] [Related]
6. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
7. Invulnerability of retinal ganglion cells to NMDA excitotoxicity.
Ullian EM; Barkis WB; Chen S; Diamond JS; Barres BA
Mol Cell Neurosci; 2004 Aug; 26(4):544-57. PubMed ID: 15276156
[TBL] [Abstract][Full Text] [Related]
8. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat.
Nucci C; Tartaglione R; Rombolà L; Morrone LA; Fazzi E; Bagetta G
Neurotoxicology; 2005 Oct; 26(5):935-41. PubMed ID: 16126273
[TBL] [Abstract][Full Text] [Related]
10. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.
Lipton SA
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S38-46. PubMed ID: 12852433
[TBL] [Abstract][Full Text] [Related]
11. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
12. Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension.
Kim JH; Lee NY; Jung SW; Park CK
Neuroscience; 2007 Nov; 149(4):908-16. PubMed ID: 17942238
[TBL] [Abstract][Full Text] [Related]
13. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
Lipton SA
Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
[TBL] [Abstract][Full Text] [Related]
14. A role for polyamines in retinal ganglion cell excitotoxic death.
Pernet V; Bourgeois P; Di Polo A
J Neurochem; 2007 Nov; 103(4):1481-90. PubMed ID: 17714450
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists.
Chen YN; Yamada H; Mao W; Matsuyama S; Aihara M; Araie M
Brain Res; 2007 May; 1148():28-37. PubMed ID: 17368577
[TBL] [Abstract][Full Text] [Related]
18. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
Lipton SA
NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
[TBL] [Abstract][Full Text] [Related]
19. Saving the nerve from glaucoma: memantine to caspaces.
Naskar R; Vorwerk CK; Dreyer EB
Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
[TBL] [Abstract][Full Text] [Related]
20. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
